In the Journal of mHealth, Within3 Chief Technology Officer Jason Smith writes about the value of patient insights and how pharma teams can harness them to their full potential.
“The quest for these ‘a-ha’ moments extends beyond data accumulation; it involves delving into the intricate tapestry of patient experiences, clinical trials, and drug reactions,” writes Smith. “The power of these insights lies in their rarity and transformative capability to shape strategies and cater directly to customer needs.”
When repurposed effectively, patient insights pave the way for a future that is more attuned to the needs of those it serves. This reorientation fosters an environment where patients are not just recipients of care but active participants in their own health journey, improving care for others as well. Insights facilitate the creation of tailored solutions and treatments, steering healthcare toward a more empathetic and patient-centric future.
“It is imperative to understand that patient insights are not just data points but narratives that transcend the confines of clinical trials and drug reactions,” says Smith. “Insights guide the healthcare industry toward a more compassionate and effective approach.”
Read the full article in Journal of mHealth.
